Posted on

is cbd oil good for parkinson’s

If you are at an office or shared network, you can ask the network administrator to run a scan across the network looking for misconfigured or infected devices.

Completing the CAPTCHA proves you are a human and gives you temporary access to the web property.

If you are on a personal connection, like at home, you can run an anti-virus scan on your device to make sure it is not infected with malware.

What can I do to prevent this in the future?

Cloudflare Ray ID: 665425931d97376e • Your IP : 185.230.143.81 • Performance & security by Cloudflare

When it comes to evidence of the benefits of cannabis-based products for people with Parkinson’s, the jury is definitely out.

However, 87% of people who hadn’t used cannabis-derived products said they would want a doctor or pharmacist to prescribe them.

The legal stuff

In fact, we’re funding a clinical trial through our Virtual Biotech right now. In a world first clinical trial, Professor Sagnik Bhattacharyya and Dr Latha Velayudhan at Kings College London (KCL) will be testing whether cannabidiol (CBD) can treat Parkinson’s psychosis symptoms.

However, people who hadn’t used them said they were worried about potential side effects and interactions with Parkinson’s medication.

Cannabis is a class-B controlled drug in the UK. Possessing, producing and supplying it are all against the law. ‘Supply’ includes sharing the drug with someone or giving it (even for free) to friends or relatives.

In a world first clinical trial, researchers will test whether cannabidiol (CBD) can treat Parkinson’s psychosis symptoms with the help of the Virtual Biotech.

Our Virtual Biotech operates in the same way but instead of doing it for profit, like a standard biotech, we’re doing it for people affected by Parkinson’s. We don’t own our own labs, hi-tech specialist equipment or employ a team of scientists because this would be enormously expensive. Instead, we’re taking an efficient approach. Partnering with institutions and pharmaceutical companies worldwide that already have the expertise, tools and infrastructure. In a chronically underfunded area, this means more money can be put into promising treatments.

What’s CBD?

Hallucinations and delusions are common symptoms of Parkinson’s. Around 60% of people experience these distressing symptoms. Current treatments can make other Parkinson’s symptoms worse, as they block dopamine receptors in the brain. This makes this research even more exciting as the existing information we have on CBD suggests it has no side effects.

This project is the first clinical trial to go through the Virtual Biotech and the 6th project overall.

CBD is a compound found in the cannabis plant. Unlike another component, THC, CBD is non-addictive and doesn’t cause intoxication. You may have already heard of it because of its potential as a treatment for epilepsy and multiple sclerosis.